Brief: Windtree Announces Positive Phase 2B Topline Clinical Results Of Istaroxime

Windtree Therapeutics

30/09/2024 13:44

Sept 30 (Reuters) - Windtree Therapeutics Inc  WINT.O :
    * WINDTREE ANNOUNCES POSITIVE PHASE 2B TOPLINE CLINICAL
RESULTS
WITH ISTAROXIME SIGNIFICANTLY IMPROVING CARDIAC FUNCTION AND
BLOOD PRESSURE IN HEART FAILURE PATIENTS IN EARLY CARDIOGENIC
SHOCK
    * WINDTREE THERAPEUTICS INC - ISTAROXIME IMPROVES SYSTOLIC
BLOOD
PRESSURE, CARDIAC OUTPUT, RENAL FUNCTION
    * WINDTREE THERAPEUTICS INC - NYHA HEART FAILURE
CLASSIFICATION
IMPROVED UP TO 72 HOURS
    * WINDTREE THERAPEUTICS INC - STUDY MEETS PRIMARY ENDPOINT
IN
IMPROVING SYSTOLIC BLOOD PRESSURE

Source text for Eikon:  urn:newsml:reuters.com:*:nGNXb3BM9q
Further company coverage:  WINT.O 

 ((Reuters.Briefs@thomsonreuters.com;))